Investing, US News

Johnson & Johnson Anticipates Covid Vaccine Sales of $2.5 Billion in 2021

amazon covid vaccination

Johnson & Johnson (NYSE:JNJ) is expecting its COVID-19 vaccine to reach $2.5 billion in sales this year, despite concerns about the injection’s efficacy against the dreaded Delta variant. [soros] Q2 2021 hedge fund letters, conferences and more Second Quarter Results On Wednesday, the company released its financial results for the second quarter, beating Wall Street […]

The post Johnson & Johnson Anticipates Covid Vaccine Sales of $2.5 Billion in 2021 appeared first on ValueWalk.

Jump To The Original Source

Facebook Comments

Check Also

Asian nations impose stricter COVID-19 restrictions due to Delta outbreaks

Published by Reuters (Reuters) – Asian countries from ...

Archives